Moreover, PVRL1 (CD111, nectin-1) promotes TIGIT-mediated T cell suppression by stabilizing CD155 on the surface of HCC tumor cells, and PVRL1 knockdown in tumor cells in an HCC mouse model resulted in reduced tumor growth in a CD8+ T cell-dependent manner (37). Here, TIGIT is linked to neoplasm.